Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

LIC-R2 Values Predict Severity of SCD: Baseline Data from Licnet-S

Rosario Di Maggio, MD, Angela Vitrano, PhD, Carmelo Fidone, MD, Alessandra Quota, MD, Daniela Fiorino, MD, Calogera Gerardi, MD, Saveria Campisi, MD, Lorenzo Tesé, MD, Vincenzo Santoro, MD, Barone Rita, MD, Giangreco Antonino, MD, Paolo Rigano, Lorella Pitrolo, MD, Aurelio Maggio, MD

Blood (2019) 134 (Supplement_1): 4810.

https://doi.org/10.1182/blood-2019-124728

Published: 2019

Journal Articles

Selecting ß-Thalassemia Patients for Gene Therapy: A Decision-Making Algorithm

Donatella Baronciani, MD, Maddalena Casale, MD, Lucia De Franceschi, MD, Giovanna Graziadei, MD, Filomena Longo, MD, Raffaella Origa, MD, Valeria Maria Pinto, MD, Paolo Rigano, MD, Monia Marchetti, MD, Antonia Gigante, Emanuele Angelucci, MD, Maria Domenica Cappellini, MD, Achille Iolascon, MD PhD, Antonio Piga, Gian Luca Forni

Blood (2019) 134 (Supplement_1): 972.

https://doi.org/10.1182/blood-2019-128320

Published: 2019

Journal Articles

Access to emergency departments for acute events and identification of sickle cell disease in refugees

Lucia De Franceschi, Caterina Lux, Frédéric B. Piel, Barbara Gianesin, Federico Bonetti, Maddalena Casale, Giovanna Graziadei, Roberto Lisi, Valeria Pinto, Maria Caterina Putti, Paolo Rigano, Rossellina Rosso, Giovanna Russo, Vincenzo Spadola, Claudio Pulvirenti, Monica Rizzi, Filippo Mazzi, Giovanbattista Ruffo, Gian Luca Forni

Blood (2019) 133 (19): 2100–2103.

https://doi.org/10.1182/blood-2018-09-876508

Published: 2019

Journal Articles

Transfusion Therapy in a Multi-Ethnic Sickle Cell Population Real-World Practice. a Preliminary Data Analysis of Multicentre Survey

Blood (2018) 132 (Supplement 1): 2389.

https://doi.org/10.1182/blood-2018-99-115938

Published: 2018

Journal Articles

Safety and Efficacy of Direct-Acting Antiviral Drugs in Patients with Haemoglobinophaties and Chronic Hepatitis C Infection

Antonio Piga, MD, Paolo Rigano, MD, Raffaella Origa, MD, M. Domenica Cappellini, MD, Valeria Pinto, MD, Immacolata Tartaglione, MD, Aldo Filosa, MD, Domenico D'Ascola, MD, Vito Di Marco, Gian Luca Forni, MD

Blood (2016) 128 (22): 3627.

https://doi.org/10.1182/blood.V128.22.3627.3627

Published: 2016

Journal Articles

Lower Levels of LPI in Thalassemia Major Patients Treated with Deferasirox

Alice Pecoraro, DR, Angela Vitrano, PhD, Antonio Troia, DR, Maria Fustaneo, MD, Lorella Pitrolo, MD, Paolo Rigano, MD, Aurelio Maggio, MD, Rosalba Di Marzo, DR

Blood (2016) 128 (22): 4821.

https://doi.org/10.1182/blood.V128.22.4821.4821

Published: 2016

Journal Articles

Survival Comparability Between Thalassemia Major Versus Thalassemia Intermedia

Blood (2015) 126 (23): 2141.

https://doi.org/10.1182/blood.V126.23.2141.2141

Published: 2015

Journal Articles

Congenital Dyserythropoietic Anemias: Molecular Diagnosis and Diagnostic Approach in a Cohort of Italian Patients

Veronica Agrigento, Sclafani Serena, Paolo Rigano, Rita Barone, Giuseppina Calvaruso, Rosario Di Maggio, Massimiliano Sacco, Lorella Pitrolo, Angela Vitrano, Aurelio Maggio, Elena D'Alcamo

Blood (2015) 126 (23): 2142.

https://doi.org/10.1182/blood.V126.23.2142.2142

Published: 2015

Journal Articles

Chronic Administration of Hydroxyurea (HU) and Outcomes in Patients with Sickle Cell Disease (SCD) at a Single Referral Institution

Rosario Di Maggio, MD, Matthew Hsieh, MD, Courtney Fitzhugh, MD, Xiongce Zhao, PhD, Giusi Calvaruso, MD, Paolo Rigano, MD, Disma Renda, Sergio Siragusa, MD, John F. Tisdale, MD, Aurelio Maggio, MD

Blood (2014) 124 (21): 4925.

https://doi.org/10.1182/blood.V124.21.4925.4925

Published: 2014

Journal Articles

Repeated Echocardiographic Left Ventricular Ejection Fraction Measurements: A Strong and Accessible Tool for Detecting At High Risk of Heart Failure Thalassemia Major Population,

Blood (2011) 118 (21): 3197.

https://doi.org/10.1182/blood.V118.21.3197.3197

Published: 2011

Journal Articles

Long-Term Use of Deferiprone Enhances Significantly the Left Ventricular Ejection Function in Thalassemia Major

Blood (2011) 118 (21): 5302.

https://doi.org/10.1182/blood.V118.21.5302.5302

Published: 2011

Journal Articles

Neridronate (NE) for the Treatment of Osteoporosis In Patients with β-Thalassemia: Results from an Italian Multicenter Randomized, Open Label, Phase II Trial

Gian Luca Forni, MD, Silverio Perrotta, MD, Caterina Borgna Pignatti, MD, Domenico Giuseppe D'Ascola, MD, Bruno Nobili, MD, Lorella Pitrolo, MD, Giovanni Quarta, MD, Paolo Rigano, MD, Laura Zanaboni, MD, Ernesto Palummeri, MD

Blood (2010) 116 (21): 4282.

https://doi.org/10.1182/blood.V116.21.4282.4282

Published: 2010

Journal Articles

Peculiar Hepatocellular Carcinoma Clinical Findings in patients with Thalassemia Syndromes.

Gaetano Restivo, Franco Valenza, Fabio D'Amato, Angela Vitrano, Paolo Rigano, Disma Renda, Filippo Cassarà, Aurelio Maggio, MD

Blood (2009) 114 (22): 5108.

https://doi.org/10.1182/blood.V114.22.5108.5108

Published: 2009

Journal Articles

Decrease of Mortality during Deferiprone Treatments: Results from A Large Randomised Cohort of Thalassemia Major Patients Under the Auspices of the Italian Society for Thalassemia and Hemoglobinopathies

Blood (2008) 112 (11): 3885.

https://doi.org/10.1182/blood.V112.11.3885.3885

Published: 2008

Journal Articles

Hematological and Clinical Findings Predictive of Mortality in Italian Patients with Sickle-Cell Disease: A Case-Control Study.

Aurelio Maggio, MD, Veronica Di Salvo, MD, Paolo Rigano, MD, Antonino Giangreco, MD, Maria Concetta Renda, PhD, Disma Renda, MD

Blood (2006) 108 (11): 3780.

https://doi.org/10.1182/blood.V108.11.3780.3780

Published: 2006

Journal Articles

Treatment with Hydroxyurea in Sickle Cell/ ß Thalassemia: A Long-Term Experience.

Aurelio Maggio, MD, Paolo Rigano, MD, Disma Renda, MD

Blood (2004) 104 (11): 1678.

https://doi.org/10.1182/blood.V104.11.1678.1678

Published: 2004

NARROW

LIC-R2 Values Predict Severity of SCD: Baseline Data from Licnet-S

Selecting ß-Thalassemia Patients for Gene Therapy: A Decision-Making Algorithm

Access to emergency departments for acute events and identification of sickle cell disease in refugees

Transfusion Therapy in a Multi-Ethnic Sickle Cell Population Real-World Practice. a Preliminary Data Analysis of Multicentre Survey

Safety and Efficacy of Direct-Acting Antiviral Drugs in Patients with Haemoglobinophaties and Chronic Hepatitis C Infection

Lower Levels of LPI in Thalassemia Major Patients Treated with Deferasirox

Survival Comparability Between Thalassemia Major Versus Thalassemia Intermedia

Congenital Dyserythropoietic Anemias: Molecular Diagnosis and Diagnostic Approach in a Cohort of Italian Patients

Chronic Administration of Hydroxyurea (HU) and Outcomes in Patients with Sickle Cell Disease (SCD) at a Single Referral Institution

Repeated Echocardiographic Left Ventricular Ejection Fraction Measurements: A Strong and Accessible Tool for Detecting At High Risk of Heart Failure Thalassemia Major Population,

Long-Term Use of Deferiprone Enhances Significantly the Left Ventricular Ejection Function in Thalassemia Major

Neridronate (NE) for the Treatment of Osteoporosis In Patients with β-Thalassemia: Results from an Italian Multicenter Randomized, Open Label, Phase II Trial

Peculiar Hepatocellular Carcinoma Clinical Findings in patients with Thalassemia Syndromes.

Decrease of Mortality during Deferiprone Treatments: Results from A Large Randomised Cohort of Thalassemia Major Patients Under the Auspices of the Italian Society for Thalassemia and Hemoglobinopathies

Hematological and Clinical Findings Predictive of Mortality in Italian Patients with Sickle-Cell Disease: A Case-Control Study.

Treatment with Hydroxyurea in Sickle Cell/ ß Thalassemia: A Long-Term Experience.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only